Literature DB >> 19175759

Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan.

Hiroyuki Uchida1, Takefumi Suzuki, David C Mamo, Benoit H Mulsant, Kenichi Tsunoda, Hiroyoshi Takeuchi, Toshiaki Kikuchi, Shinichiro Nakajima, Kensuke Nomura, Masayuki Tomita, Koichiro Watanabe, Haruo Kashima.   

Abstract

Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross-sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean +/- SD age, 52 +/- 17 years; age range, 16- 91 years) was conducted in Japan. The use of benzodiazepine-derivative anxiolytics was approximately 60% in all decades, including older patients, without a group difference. The frequent use of benzodiazepines is a cause for concern because they are not preferred treatment, given their well-known adverse effects especially in the elderly.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19175759     DOI： 10.1111/j.1440-1819.2008.01920.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


  7 in total

Review 1.  A tipping point in drug dosing in late-life schizophrenia.

Authors:  Takashi Tsuboi; Takefumi Suzuki; Hiroyuki Uchida
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

2.  Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization.

Authors:  Jun Kohyama
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

3.  Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.

Authors:  Tasuku Hashimoto; Akihiro Shiina; Tadashi Hasegawa; Hiroshi Kimura; Yasunori Oda; Tomihisa Niitsu; Masatomo Ishikawa; Masumi Tachibana; Katsumasa Muneoka; Satoshi Matsuki; Michiko Nakazato; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2016-10-19       Impact factor: 3.455

4.  Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.

Authors:  Yoshikazu Takaesu; Koichiro Watanabe; Shusuke Numata; Masaaki Iwata; Noriko Kudo; Satoru Oishi; Takeya Takizawa; Kiyotaka Nemoto; Yuka Yasuda; Hiromi Tagata; Takashi Tsuboi; Naohisa Tsujino; Naoki Hashimoto; Yuki Matsui; Hikaru Hori; Hidenaga Yamamori; Nobuhiro Sugiyama; Taro Suwa; Taishiro Kishimoto; Akitoyo Hishimoto; Masahide Usami; Ryuji Furihata; Kunihiro Iwamoto; Hiroshige Fujishiro; Toshinori Nakamura; Kentaro Mizuno; Takahiko Inagaki; Eiichi Katsumoto; Hiroaki Tomita; Kazutaka Ohi; Hiroyuki Muraoka; Kiyokazu Atake; Hitoshi Iida; Tatsuya Nagasawa; Junichi Fujita; Satoshi Yamamura; Toshiaki Onitsuka; Atsunobu Murata; Yoichiro Takayanagi; Hokuto Noda; Yukiko Matsumura; Kenji Takezawa; Jun-Ichi Iga; Kayo Ichihashi; Kazuyoshi Ogasawara; Hisashi Yamada; Ken Inada; Ryota Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-08-22       Impact factor: 5.188

5.  Persistence and compliance to antidepressant treatment in patients with depression: a chart review.

Authors:  Norifusa Sawada; Hiroyuki Uchida; Takefumi Suzuki; Koichiro Watanabe; Toshiaki Kikuchi; Takashi Handa; Haruo Kashima
Journal:  BMC Psychiatry       Date:  2009-06-16       Impact factor: 3.630

6.  Factors affecting hallucinations in patients with delirium.

Authors:  Masako Tachibana; Toshiya Inada; Masaru Ichida; Norio Ozaki
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

7.  Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Authors:  Shusuke Numata; Masahito Nakataki; Naomi Hasegawa; Yoshikazu Takaesu; Masahiro Takeshima; Toshiaki Onitsuka; Toshinori Nakamura; Reon Edagawa; Hiroaki Edo; Kenichiro Miura; Junya Matsumoto; Norio Yasui-Furukori; Taishiro Kishimoto; Hikaru Hori; Takashi Tsuboi; Yuka Yasuda; Ryuji Furihata; Hiroyuki Muraoka; Shinichiro Ochi; Tatsuya Nagasawa; Yoshitaka Kyou; Atsunobu Murata; Eiichi Katsumoto; Kazutaka Ohi; Akitoyo Hishimoto; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.